| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/19/2009 | CA2276164C Injectable implant |
| 05/19/2009 | CA2210891C Valaciclovir tablets containing colloidal silicon dioxide |
| 05/19/2009 | CA2206657C Therapeutic preparation for inhalation containing parathyroid hormone, pth |
| 05/14/2009 | WO2009062193A2 Methods for administering corticosteroid formulations |
| 05/14/2009 | WO2009062136A2 Controlled delivery of insulin from thermo-sensitive polymer solution |
| 05/14/2009 | WO2009061909A2 Wet granulation using a water sequestering agent |
| 05/14/2009 | WO2009061805A1 Formulations for enhanced bioavailability of orally administered polar agents |
| 05/14/2009 | WO2009061780A1 Fast release solid formulation, preparation and use thereof |
| 05/14/2009 | WO2009061713A1 Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor |
| 05/14/2009 | WO2009061607A2 Water-immiscible materials as vehicles for drug delivery |
| 05/14/2009 | WO2009061482A2 Anesthetic composition, formulation and method of use |
| 05/14/2009 | WO2009061465A1 Chewable formulations |
| 05/14/2009 | WO2009061372A1 Systems and methods for creating multi-phase entities, including particles and/or fluids |
| 05/14/2009 | WO2009061298A1 Topical treatment with dapsone in g6pd-deficient patients |
| 05/14/2009 | WO2009061273A1 Dry powder formulations comprising ascorbic acid derivates |
| 05/14/2009 | WO2009061270A1 Device for the treatment of vaginal fungal infection |
| 05/14/2009 | WO2009061105A2 Stabilized preparation containing coenzyme q10 and process for preparation thereof |
| 05/14/2009 | WO2009061003A2 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | WO2009060915A1 Salivary secretion promoter |
| 05/14/2009 | WO2009060857A1 Method for producing membrane protein |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009060629A1 Lidocaine tape preparation |
| 05/14/2009 | WO2009060609A1 Method for producing microcapsule using solid fat |
| 05/14/2009 | WO2009060608A1 Sustained release composition containing sdf-1 |
| 05/14/2009 | WO2009060473A2 Injectable compositions, processes and uses thereof |
| 05/14/2009 | WO2009060226A1 Intranasal compositions |
| 05/14/2009 | WO2009060077A2 Intrauterine deposit |
| 05/14/2009 | WO2009060064A2 Pharmaceutical formulations for the oral administration of ppi |
| 05/14/2009 | WO2009060013A2 A method for treating ailments of the oral cavity with a krill enzyme composition |
| 05/14/2009 | WO2009059989A1 Aqueous emulsions comprising a hydrophobic active ingredient |
| 05/14/2009 | WO2009059748A2 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 05/14/2009 | WO2009059717A2 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use |
| 05/14/2009 | WO2009059701A2 Sustained release tablets with hydromorphone |
| 05/14/2009 | WO2009059510A1 Ph-sensitive solid pharmaceutical composition for oral formulation and preparation method thereof |
| 05/14/2009 | WO2009059450A1 Peptide ligand directed drug delivery |
| 05/14/2009 | WO2009059449A1 Novel thermosensitive liposomes containing therapeutic agents |
| 05/14/2009 | WO2009059425A1 Stat3 inhibitors for the treatment of fibrosis |
| 05/14/2009 | WO2009042127A3 Compositions and methods for rescuing fertility |
| 05/14/2009 | WO2009036084A3 Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach |
| 05/14/2009 | WO2009032907A3 Stay-on selenium foam |
| 05/14/2009 | WO2009031859A3 Multi-functional complex for imaging and drug delivery |
| 05/14/2009 | WO2009030351A3 Transdermal therapeutic system containing elongate hollow bodies |
| 05/14/2009 | WO2009027095A4 Aerosols for sinunasal drug delivery |
| 05/14/2009 | WO2009020987A3 Process for preparation of swellable and degradable microspheres |
| 05/14/2009 | WO2009016350A3 Stimulating gel |
| 05/14/2009 | WO2009016069A4 Stable liquid pharmaceutical composition based on trazodone |
| 05/14/2009 | WO2009013633A3 Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts |
| 05/14/2009 | WO2009009665A3 O-desmethylvenlafaxine |
| 05/14/2009 | WO2008134478A3 Increased drug loading capacity of polymeric material |
| 05/14/2009 | WO2008132727A3 Oral delivery of proteins and peptides |
| 05/14/2009 | WO2008131129A3 Nucleic acid microparticles for pulmonary delivery |
| 05/14/2009 | WO2008129191A3 Palatable product |
| 05/14/2009 | WO2008104960A3 Personal care product comprising cyclodextrin as fragrance- complexing material |
| 05/14/2009 | WO2008094659A3 Novel biomaterials for ocular drug delivery and a method for making and using same |
| 05/14/2009 | WO2008063092A3 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 05/14/2009 | WO2007135470A8 Process for the preparation and surface coating of pellets |
| 05/14/2009 | WO2007115033A3 Layered nanoparticles for sustained release of small molecules |
| 05/14/2009 | WO2007056565A3 Remote controlled in situ reaction method |
| 05/14/2009 | WO2006138503A3 New regimens for oral monophasic contraceptives |
| 05/14/2009 | WO2006116752A3 Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
| 05/14/2009 | WO2005117836A3 Polymeric microbeads having characteristics favorable for bone growth, and process including three dimensional printing upon such microbeads |
| 05/14/2009 | US20090124590 Pharmaceutical composition |
| 05/14/2009 | US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/14/2009 | US20090124586 Aqueous-based pharmaceutical composition |
| 05/14/2009 | US20090124563 Oral extended-release composition |
| 05/14/2009 | US20090124554 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/14/2009 | US20090124552 Methods and Compositions for Regenerating Connective Tissue |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/14/2009 | US20090123927 Isolation of precursor cells and their use for tissue repair |
| 05/14/2009 | US20090123573 Admixture of extracts of plants of the genus rosmarinus and carotenoids for treating cutaneous symptoms of aging |
| 05/14/2009 | US20090123557 Dietary supplement composition for blood lipid health |
| 05/14/2009 | US20090123556 Sustained release pharmaceutical compositions |
| 05/14/2009 | US20090123555 Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof |
| 05/14/2009 | US20090123554 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| 05/14/2009 | US20090123553 Peptide nanostructures and methods of generating and using the same |
| 05/14/2009 | US20090123552 Spheroids prepared from an isolated active principle of vegetable origin and a solution of vegetable origin containing the active principle or a precursor thereof |
| 05/14/2009 | US20090123551 Gastrointestinal delivery systems |
| 05/14/2009 | US20090123550 Corticosteroid compositions |
| 05/14/2009 | US20090123549 Pharmaceutical Compositions |
| 05/14/2009 | US20090123547 Methods and Compositions for Regenerating Connective Tissue |
| 05/14/2009 | US20090123546 Polymer-based, sustained release drug delivery system |
| 05/14/2009 | US20090123545 Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof |
| 05/14/2009 | US20090123544 Stimulus-responsive biodegradable polymers and methods of preparation |
| 05/14/2009 | US20090123543 Pharmaceutical compositions |
| 05/14/2009 | US20090123542 oral administered powder mixture comprising a dissolved whey protein to increase release the bioactive carotenoid, polyphenol, vitamins, flavonoid, isoflavone, ceramide |
| 05/14/2009 | US20090123541 Pharmaceutical Composition |
| 05/14/2009 | US20090123540 Sulfoalkyl ether cyclodextrin; use in pharmaceutical dosage forms as solubilizer or stabilizer |
| 05/14/2009 | US20090123539 Wet granulation using a water sequestering agent |
| 05/14/2009 | US20090123538 Angiotensin II Receptor Antagonists |
| 05/14/2009 | US20090123537 Oral dosage form of ceftriaxone and methods of use |
| 05/14/2009 | US20090123536 Oral Pharmaceutical Form of Losartan |
| 05/14/2009 | US20090123535 Oral Controlled Release Formulation for Sedatives and Hypnotic Agents |
| 05/14/2009 | US20090123534 comprising progesterone, soy bean lecithin, and olive oil, wherein at least about 80% of the particles of progesterone are characterized by a particle size of between 1 and 15 mu m; for treating a physiological condition linked to insufficiency of progesterone secretion |
| 05/14/2009 | US20090123533 Compositions and methods for cancer diagnosis and therapy |
| 05/14/2009 | US20090123532 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 05/14/2009 | US20090123531 Glutathione-based delivery system |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123529 Nucleic acid immunological composition for human metapneumovirus |
| 05/14/2009 | US20090123528 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |